Sort
10,829 grants matching “car t”
Collective Intelligence, Knowledge Infrastructure, & High Performance Computing
$2,823,000Calvin A Johnson · Center For Information Technology · ZIH · FY2010 · CT
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,807,871James L Riley · University Of Pennsylvania · U19 · FY2021 · AI
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,804,200Carl H. June · University Of Pennsylvania · P01 · FY2018 · CA
Protein Trafficking In The Endosomal-Lysosomal System
$2,797,775Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Novel cell and gene therapy for HIV cure
$2,795,881J. Victor Garcia-Martinez · University Of Alabama At Birmingham · P01 · FY2025 · AI
Models and Gene Therapies for AAT Deficiency
$2,789,128Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2021 · HL
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,782,255Carl H. June · University Of Pennsylvania · P01 · FY2023 · CA
Biochemical Basis of T Cell Activation
$2,775,630Lawrence Samelson · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,760,232Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,756,111Carl H. June · University Of Pennsylvania · P01 · FY2019 · CA
Mechanism and biological consequences of the nuclear receptor CAR activation
$2,748,882Masahiko Negishi · Environmental Health Sciences · Z01 · FY2007 · ES
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,747,943Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2018 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,745,884Robert S Negrin · Stanford University · P01 · FY2019 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,739,423Robert S Negrin · Stanford University · P01 · FY2020 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2023 · CA
Techbridge Broad Implementation: An Innovative Model to Inspire Girls in STEM Careers
$2,728,161Teresa Drew · Techbridge · · FY2013 · EDU
Models and Gene Therapies for AAT Deficiency
$2,728,017Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2023 · HL
Models and Gene Therapies for AAT Deficiency
$2,728,017Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · HL
Text Analytics, Knowledge Engineering, & High Performance Computing
$2,726,852Calvin A Johnson · Center For Information Technology · ZIH · FY2012 · CT
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
$2,721,179Mark Lee · Fisher Bioservices, Inc. · N02 · FY2021 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,710,901Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2017 · CA
BACKGROUND:CURRENT MEDICAL CAPABILITIES IN SPACE ARE VERY LIMITED; LONG-TERM SPACE MISSIONS PRESENT THE UNIQUE CHALLENGE OF PROVISION OF MEDICAL CAR
$2,700,000Board Of Regents Of The University Of Nebraska · · FY2010 · National Aeronautics and Space Administration
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,699,182James L Riley · University Of Pennsylvania · U19 · FY2022 · AI
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,696,586Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES